This site is intended for healthcare professionals only
LoginRegister
Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple StrengthsLupin Launches Strategic Partnership to Expand PrecisionSphere Long-Acting Injectable Platform
Cyber Fraud Strikes Mumbai Doctor Over Rs 2.98 LakhChemist Loses Rs 1.01 Crore in Social Media Investment Scam
Fake Drug Unit Operator Sentenced to 7-Year Jail TermBhopal Pharmacy Owner Gets 3-Year Jail Sentence for Running Store Without Pharmacist
USFDA Approves Eli Lillys Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo NordiskRs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales
Five Pharma Firms Under Regulatory Scanner Over Rs 8 Lakh Unbilled MedicinesMaharashtra FDA Launches Special Drive to Inspect Liquid Oral Formulations
Rubicon Research Raises Rs 619 Crore Pre-IPO, Eyes October 16 ListingRubicon Research Raises Rs 619 Crore Pre-IPO, Eyes October 16 Listing
Gates Foundation, PAHO Push to Make Mounjaro, Wegovy Affordable in Low-Income CountriesGates Foundation, PAHO Push to Make Mounjaro, Wegovy Affordable in Low-Income Countries
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCOAMC Flags Human Trial Violations, Refers Case to Gujarat FDCA
Amazon Enters Drug Discovery Race with AI Platform for Faster Molecule DesignAmazon Pharmacy Introduces In-Person Pickup Kiosks at One Medical Clinics
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsFludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects
IGMC Shimla viral video row: Over 2,000 resident doctors on indefinite strike demanding revocation of doctors termination orderChemists Launch Indefinite Strike Over Coldrif Tragedy, Demand Action Against Manufacturers Not...
SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab BiosimilarUnequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy Reform
X